Received Jul 2, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
patient receive the MenB (prefilled syringe) component only of the Penmenvy (was not reconstituted).; patient receive the MenB (prefilled syringe) component only of the Penmenvy (was not reconstituted).; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe for prophylaxis. On an unknown date, the patient received Penmenvy. On an unknown date, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: patient receive the MenB (prefilled syringe) component only of the Penmenvy (was not reconstituted).) and inappropriate dose of vaccine administered (Verbatim: patient receive the MenB (prefilled syringe) component only of the Penmenvy (was not reconstituted).). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-JUN-2026 The patient had a patient receive the MenB (prefilled syringe) component only of the Penmenvy (was not reconstituted). The batch number was not provided and request for this information has been made.